Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine oral solution pharmacokinetics in children with chronic kidney disease and hypertension
2013-005323-17Phase 4Active
- Sponsor
- Erasmus MC
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of amlodipine in hypertension (HTN), sponsored by Erasmus MC. Primary endpoint: Amlodipine pharmacokinetic parameters. Started May 2014; status: active.
02
Drugs
amlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2013-005323-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005323-17.